SecBot SecBot
8-K ·Filed Sep 4, 2026

CDIX

Cardiff Lexington Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001683168-26-006974
8-K context-dependent: Items 3.03
Actionable Insight • Neutral

Monitor for any future issuance of these shares, which could dilute common equity and introduce a controlling voting block. Until issued, this filing has no trading implications.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
CDIX ▼ -48.36% at T+20d
NEUTRAL call -48.36% · α vs SPY -50.33% · entry $0.1162 → $0.0600
Next anchor: T+60d in 5w
Entry = T+0 close
Sep 4, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.46%
$0.1162
settled 7w ago
T+5d
+321.60%
call +321.60% · α +322.26%
$0.4899
settled 6w ago
T+20d
-48.36%
call -48.36% · α -50.33%
$0.0600
settled 22d ago
T+60d
Pending
in 5w

Price Chart

Loading chart...

Executive Summary

Cardiff Lexington filed a Certificate of Designation creating 2 shares of Series A-1 Preferred Stock, each with a stated value of $250. The series carries no dividend rights, a liquidation preference senior to common stock but junior to several existing preferred series and all debt, and voting power equal to 25% of all other equity votes plus one. No shares have been issued; this is a routine authorization of a new preferred class with no immediate financial impact.

Key Facts

  • 2 shares of Series A-1 Preferred Stock authorized, par value $0.001 per share, stated value $250 per share.
  • No dividend rights and no economic interest in the company.
  • Liquidation preference of $250 per share, junior to Series F-1, L, N, X, Y preferred and all debt.
  • Each share has voting power equal to 25% of all other equity votes plus one.
  • Automatic conversion to 1 share of common stock upon any transfer (except to an affiliate).
  • No shares have been issued as of the filing date.

Financial Impact

No financial impact; the series is authorized but unissued.

Risk Factors

  • If issued, the 25%+1 voting power could concentrate control.
  • Automatic conversion on transfer could create overhang if placed with a strategic holder.

Market Snapshot

Exchange
OTC
Sector
Services-Offices & Clinics of Doctors of Medicine

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001683168-26-006974
Document: cardiff_8k.htm0001683168-26-006974
Document: 0001683168-26-006974-index-headers.html0001683168-26-006974
Document: 0001683168-26-006974-index.html0001683168-26-006974
Document: 0001683168-26-006974.txt0001683168-26-006974
4 reports for CDIX
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+60▲ +91.70%Jun 11, 2026
Filters
Rows
Reports for CDIX — sortable, filterable
TypeNow
Sep 4, 2026
7w ago
8-K
NEUTRAL ★ 2/10
$0.1162awaiting T+60—$0.0250 (−78.49%)
Jun 22, 2026
18w ago
EFFECT
BEARISH ★ 7/10
$1.80 $0.4899▲ +72.78%▲ +75.00%$0.0250 (+98.61%)
Jun 11, 2026
19w ago
S-1
BEARISH ★ 6/10
$1.40 $0.1162▲ +91.70%▲ +95.23%$0.0250 (+98.21%)
Jun 11, 2026
19w ago
8-K
BEARISH ★ 6/10
$1.40 $0.1162▲ +91.70%▲ +95.23%$0.0250 (+98.21%)
Showing 4 of 4

US Market Status

Market Closed — Opens Wed (11h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 4, 2026